CAV1 and neoplasm: The fact that caveolin-1 is capable of suppressing the activity of many components of growth factor signalling pathways (e.g., the EGFR and components of the p42/44 MAPK pathway [86, 88]), makes it an attractive candidate tumour suppressor gene, and several lines of evidence support this proposal.